These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
269 related items for PubMed ID: 10688045
1. Detection of loss of heterozygosity in the p53 tumor-suppressor gene with PCR in the urine of patients with bladder cancer. Friedrich MG, Erbersdobler A, Schwaibold H, Conrad S, Huland E, Huland H. J Urol; 2000 Mar; 163(3):1039-42. PubMed ID: 10688045 [Abstract] [Full Text] [Related]
2. TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples. Dahse R, Utting M, Werner W, Schimmel B, Claussen U, Junker K. Int J Oncol; 2002 Jan; 20(1):107-15. PubMed ID: 11743649 [Abstract] [Full Text] [Related]
3. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment. Bartoletti R, Dal Canto M, Cai T, Piazzini M, Travaglini F, Gavazzi A, Rizzo M. Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429 [Abstract] [Full Text] [Related]
5. Transitional cell bladder tumor: predicting recurrence and progression by analysis of microsatellite loss of heterozygosity in urine sediment and tumor tissue. Fornari D, Steven K, Hansen AB, Jepsen JV, Poulsen AL, Vibits H, Horn T. Cancer Genet Cytogenet; 2006 May; 167(1):15-9. PubMed ID: 16682280 [Abstract] [Full Text] [Related]
6. [Microsatellite instability in urine sediments from patients with transitional cell carcinoma of bladder and its clinical value]. Lü Y, Tang D, Yu L, Ding Y, Liu L, Guo Y. Zhonghua Wai Ke Za Zhi; 2000 Apr; 38(4):294-6. PubMed ID: 12828175 [Abstract] [Full Text] [Related]
9. High-throughput molecular analysis of urine sediment for the detection of bladder cancer by high-density single-nucleotide polymorphism array. Hoque MO, Lee J, Begum S, Yamashita K, Engles JM, Schoenberg M, Westra WH, Sidransky D. Cancer Res; 2003 Sep 15; 63(18):5723-6. PubMed ID: 14522891 [Abstract] [Full Text] [Related]
10. Detection of loss of heterozygosity in the p53 tumor suppressor gene using a PCR-based assay. Ridanpää M, Anttila S, Husgafvel-Pursiainen K. Pathol Res Pract; 1995 Jun 15; 191(5):399-402. PubMed ID: 7479357 [Abstract] [Full Text] [Related]
13. Progression in transitional cell carcinoma of the urinary bladder--analysis of Tp53 gene mutations by temperature gradients and sequence in tumor tissues and in cellular urine sediments. Schlechte HH, Sachs MD, Lenk SV, Brenner S, Rudolph BD, Loening SA. Cancer Detect Prev; 2000 Jun 15; 24(1):24-32. PubMed ID: 10757120 [Abstract] [Full Text] [Related]
15. Frequent association of p53 gene mutation in invasive bladder cancer. Fujimoto K, Yamada Y, Okajima E, Kakizoe T, Sasaki H, Sugimura T, Terada M. Cancer Res; 1992 Mar 15; 52(6):1393-8. PubMed ID: 1540947 [Abstract] [Full Text] [Related]
16. Bladder cancer: allelic deletions at and around the retinoblastoma tumor suppressor gene in relation to stage and grade. Wada T, Louhelainen J, Hemminki K, Adolfsson J, Wijkström H, Norming U, Borgström E, Hansson J, Sandstedt B, Steineck G. Clin Cancer Res; 2000 Feb 15; 6(2):610-5. PubMed ID: 10690546 [Abstract] [Full Text] [Related]